title: The endocannabinoid system: A novel player in human placentation.
abstract: Cannabis sativa is the most consumed illegal drug around the world. Its consumption during pregnancy is associated with gestational complications, particularly with fetal growth restriction. Endocannabinoids (eCBs) are lipid molecules that act by activating the G-protein coupled cannabinoid receptors, which are also target of the phytocannabinoid Δ(9)-tetrahydrocannabinol (THC). The endocannabinoid system (ECS) participates in distinct biological processes, including pain, inflammation, neuroprotection, and several reproductive events. In addition, an abnormal expression of ECS is associated with infertility and miscarriages. This manuscript will review and discuss the expression of ECS in normal and pathological human placentas, and the role of eCBs and THC in trophoblast proliferation, apoptosis, differentiation, and function. The current evidence points towards a role of ECS in human placentation, shedding light on the contribution of the eCBs in the coordination of human placentation, and in the cellular mechanisms underlying the deleterious effects of cannabis consumption during pregnancy.
authors.affiliation: PhD in Pharmaceutical Sciences by Faculdade de Farmácia, Universidade do Porto, Porto, Portugal. Electronic address: marianaac@sapo.pt.
authors.forename: M A
authors.initials: MA
authors.lastname: Costa
mesh_terms: D000818:Animals; D063388:Endocannabinoids / Q000378:metabolism*; D005260:Female; D006801:Humans; D010920:Placenta / Q000378:metabolism*; D010929:Placentation; D011247:Pregnancy; D014327:Trophoblasts / Q000378:metabolism
chemical_list: D063388:Endocannabinoids
keywords: 2-arachinodoylglycerol; Anandamide; Cannabis; Cytotrophoblast; Endocannabinoid system; Human placenta; Syncytiotrophoblast; Δ(9)-tetrahydrocannabinol